Sense Neuro Diagnostics

Sense Neuro Diagnostics

Private
Cincinnati, OhioHealthcare & Life Scienceshttps://senseneuro.com

Last Round

Series B

Oct 3, 2025

Total Funding Raised

$5.98M

Momentum Score

50 /100

Company Overview

Sense Neuro Diagnostics is a healthtech company that is developing non-invasive technology to enable rapid, comprehensive detection of stroke and traumatic brain injury, and continuous monitoring of brain injury.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Health IoT, Defense Tech

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts, Hardware + Subscription

AI Layer

Application

Keywords

stroke detectionTBI detectiontraumatic brain injury detectionnon-invasive brain scannerportable medical devicemedical imagingAI medical diagnosticspoint of care diagnosticsPOC diagnosticscontinuous brain monitoringstroke triageRF brain scanningbrain bleed detectionmedtechEMS technologydefense techB2Gmedical disposables

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sense Neuro Diagnostics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Sense Neuro Diagnostics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BOct 3, 2025
VC RoundFeb 10, 2025
GrantNov 4, 2024
StrategicMar 20, 2023
GrantAug 2, 2021
Series A
Mar 16, 2017

Key People

Founding team and executive leadership

Gary Kurdziel

Chief Executive Officer

Executive Team

Geoffrey Klass

Chief Executive Officer, CEO

Executive Team

George Shaw

Chief Technology Officer

Executive Team

Paul Gaitan

Chief Financial Officer

Executive Team

Sense Neuro Diagnostics Investors

Notable investors and investment history

InvestorRounds
QCA VenturesVC Round, Series A, Series B
U.S. Department of DefenseGrant
Accelerant DaytonVC Round, Series B
Bearcat VenturesVC Round, Series B
Medical Technology Enterprise ConsortiumGrant
Alloy Growth LabVC Round, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2025

    Gary Kurdziel appointed as new Chief Executive Officer.

  • Mar 21, 2025

    Eric Bailey joins as the new Chief Commercial Officer.

Sense Neuro Diagnostics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sense Neuro Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sense Neuro Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCincinnati, Ohio
Employee Range13
Year Founded2014
Last FundingOct 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.